Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00003077 · ClinicalTrials.gov registry record · Phase 1
Omega-3 Fatty Acids in Treating Patients With Advanced Cancer Who Have Significant Weight Loss
A Phase 1 study, sponsored by Alliance for Clinical Trials in Oncology.
- Completed
- Registry status
- Phase 1
- Development phase
- 63
- Enrollment target
NCT00003077 is a Phase 1 study that has completed, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 63 participants.
The verdict
NCT00003077, a Phase 1 study, has completed, sponsored by Alliance for Clinical Trials in Oncology.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 63 participants
- Enrollment target
Study Summary
RATIONALE: Omega-3 fatty acids are used by the body for energy and tissue development and may be an effective treatment for patients with advanced cancer who are unable to maintain their body weight. PURPOSE: Phase I/II trial to study the effectiveness of omega-3 fatty acids in treating patients with advanced cancer who have significant weight loss.
Interventions
- DIETARY_SUPPLEMENT omega-3 fatty acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 1995-10 |
| Est. Completion | 2004-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00003077
The ClinicalTrials.gov registry entry for NCT00003077 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 63 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alliance for Clinical Trials in Oncology, which has 446 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which omega-3 fatty acid is the first listed.
NCT00003077 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00003077 about?
NCT00003077 is a clinical study titled "Omega-3 Fatty Acids in Treating Patients With Advanced Cancer Who Have Significant Weight Loss". RATIONALE: Omega-3 fatty acids are used by the body for energy and tissue development and may be an effective treatment for patients with advanced cancer who are unable to maintain their body weight. PURPOSE: Phase I/II trial to study the effectiveness of omega-3 fatty acids in treating patients wi...
What is the current status of trial NCT00003077?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 63 participants. The study started on 1995-10. Estimated completion is 2004-11.
What interventions are being tested in trial NCT00003077?
The interventions under investigation include: omega-3 fatty acid (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00003077?
This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.